According to Gram Research analysis, a new drug called soraphen A reduced psoriasis-like skin inflammation in mice eating Western diets by decreasing skin redness, thickening, and inflammatory immune cells, but had no effect in mice eating normal diets. This suggests the drug may specifically help people whose psoriasis worsens from unhealthy eating patterns, though human studies are needed to confirm this approach works in people.
Researchers tested a new drug called soraphen A to see if it could help reduce psoriasis symptoms, especially in people eating unhealthy Western diets. Psoriasis is an inflammatory skin condition where the immune system attacks healthy skin cells. In this study, mice fed a Western diet and treated with soraphen A before getting psoriasis showed less redness, thinner skin, and fewer inflammatory immune cells compared to untreated mice. The drug didn’t help mice eating normal diets, suggesting it may work best for people whose psoriasis is worsened by poor diet choices. While results are promising, this research was done in mice, so more testing is needed before doctors could prescribe this treatment to humans.
Key Statistics
A 2026 research study in mice found that soraphen A reduced skin redness and thickening in animals eating Western diets, while producing no measurable effects in mice eating normal diets.
In mice treated with soraphen A and fed Western diets, the number of IL-17-producing immune cells in skin-draining lymph nodes was significantly reduced compared to untreated mice, suggesting the drug targets specific inflammatory pathways.
Soraphen A reduced neutrophil infiltration in the liver of Western diet-fed mice, indicating anti-inflammatory effects beyond the skin, though fatty liver deposits remained unchanged.
The Quick Take
- What they studied: Whether a new drug called soraphen A could reduce psoriasis symptoms in mice, especially those eating unhealthy Western diets high in fat and processed foods
- Who participated: Female laboratory mice divided into groups: some ate normal healthy diets and others ate Western-style diets high in fat. All mice were treated with the drug or a placebo before being exposed to a chemical that triggers psoriasis-like skin inflammation
- Key finding: In mice eating Western diets, soraphen A reduced skin redness, skin thickening, and the number of inflammatory immune cells compared to untreated mice. The drug had no effect in mice eating normal diets
- What it means for you: This research suggests that a new type of drug targeting fat production in immune cells might help people with psoriasis that gets worse from eating unhealthy diets. However, this was tested only in mice, so human studies are needed before this could become a treatment option
The Research Details
Scientists used laboratory mice to test whether soraphen A could prevent psoriasis-like skin disease. They divided mice into groups: some ate normal diets and others ate Western diets (high in fat and processed foods) for 12 weeks. Then half of each group received soraphen A injections for 10 days while the other half got placebo injections. After that, all mice had a chemical applied to their skin to trigger psoriasis-like inflammation. Researchers then measured skin changes, looked at skin samples under microscopes, tested immune cells in the blood, and examined liver tissue. This approach allowed them to see whether the drug worked differently depending on diet and whether it affected the immune system.
This research design is important because psoriasis in real people is often worse when they eat unhealthy diets. By testing the drug in mice eating different diets, researchers could see if the treatment works specifically for diet-related psoriasis. The study also measured multiple outcomes (skin appearance, immune cells, and liver health) to get a complete picture of how the drug works and whether it causes side effects
This study was published in a respected scientific journal and used careful laboratory methods to measure results. The researchers used multiple ways to assess psoriasis (visual inspection, microscope examination, immune cell counting, and genetic testing) which strengthens confidence in findings. However, this is animal research, so results may not directly apply to humans. The study was relatively short term (only 15 days of treatment and observation), so long-term effects are unknown
What the Results Show
In mice eating Western diets, soraphen A treatment reduced skin redness and skin thickening compared to untreated mice. The drug also reduced the thickness of the outer skin layer, which normally becomes abnormally thick in psoriasis. Importantly, the drug reduced the number of specific immune cells called IL-17-producing T cells in the lymph nodes that drain the skin. These cells are known to drive psoriasis inflammation. In mice eating normal diets, soraphen A had no measurable effect on any of these measures, suggesting the drug only works when the immune system is already stressed by an unhealthy diet. The drug did not reduce skin scaling, which is another common psoriasis symptom.
The researchers also looked at liver health because Western diets can cause fatty liver disease. Soraphen A did not reduce fatty deposits in the liver, but it did reduce the number of immune cells called neutrophils that had infiltrated the liver tissue. This suggests the drug may have some anti-inflammatory effects beyond the skin. The drug did not affect a type of immune cell called gamma-delta T cells, indicating it targets specific immune pathways rather than broadly suppressing immunity
Previous research has shown that fatty acid synthesis (the process of making fats in the body) is important for creating IL-17-producing T cells, which drive psoriasis. This study confirms that blocking this fat-making process with soraphen A can reduce these harmful immune cells. The finding that the drug only works in mice eating Western diets aligns with clinical observations that psoriasis patients often experience worse flare-ups when eating unhealthy diets. This research suggests a new way to think about psoriasis treatment: targeting the metabolic stress caused by poor diet rather than just suppressing the immune system broadly
This research was conducted only in mice, and results may not translate to humans. The study used only female mice, so results may differ in males. The treatment period was short (10 days of drug plus 5 days of skin irritation), so long-term effects are unknown. The drug was given by injection, which is not practical for long-term human use. The study did not test different doses of the drug, so the optimal dose for humans is unclear. Finally, the drug did not reduce all psoriasis symptoms (scaling remained unchanged), suggesting it may not be a complete solution
The Bottom Line
Based on this research, soraphen A shows modest promise for treating psoriasis in people whose condition is worsened by Western diet patterns. However, this is early-stage research in animals. Confidence level: Low to Moderate. Before considering this as a treatment, human clinical trials are needed to confirm safety and effectiveness. People with psoriasis should continue following current treatment recommendations from their dermatologists while this research progresses
This research is most relevant to people with psoriasis whose symptoms worsen with unhealthy eating patterns. It may also interest people interested in how diet influences immune diseases. Dermatologists and immunologists studying psoriasis should follow this research. People without psoriasis or those whose psoriasis is not diet-related may see less direct benefit from this finding
If this research advances to human trials, it would typically take 5 to 10 years before a new drug could become available to patients. Even if human trials are successful, the drug would need to be reformulated for practical use (likely as a pill rather than injections). People should not expect this treatment to become available in the near term
Frequently Asked Questions
Can soraphen A treat psoriasis in humans right now?
Not yet. This research was conducted only in mice. Human clinical trials would be needed to determine if the drug is safe and effective for people with psoriasis. This is early-stage research that may take years to develop into a human treatment
Does diet really affect psoriasis severity?
This research suggests diet plays a role, at least in mice. The drug only worked in mice eating Western diets, not those eating normal diets. Many psoriasis patients report that unhealthy eating worsens their symptoms, though more human research is needed to fully understand this connection
What is soraphen A and how does it work?
Soraphen A is an experimental drug that blocks enzymes called ACC1 and ACC2, which control how the body makes fats. By reducing fat production, the drug appears to reduce the creation of inflammatory immune cells that drive psoriasis. It targets the metabolic stress caused by unhealthy diets
Should I change my diet if I have psoriasis?
This research suggests that reducing Western diet foods (processed foods, excess fat, sugar) may help reduce psoriasis flare-ups, especially if your symptoms worsen after eating unhealthy foods. Talk to your dermatologist about dietary changes that might help your specific situation
Why did the drug only work in mice eating Western diets?
Unhealthy diets stress the immune system and increase fat production in immune cells. Soraphen A appears to work by blocking this diet-related metabolic stress. In mice eating normal diets, the immune system wasn’t under this metabolic stress, so the drug had nothing to counteract
Want to Apply This Research?
- Track daily psoriasis severity using a simple 1-10 scale for redness, itching, and skin thickness. Also log daily diet quality (number of servings of processed foods versus whole foods) to identify patterns between diet and symptom flare-ups
- Use the app to set a goal of reducing Western diet foods (fried foods, sugary drinks, processed snacks) by 25% over 4 weeks. Log meals and psoriasis symptoms daily to see if reducing unhealthy foods correlates with fewer or less severe flare-ups
- Create a monthly report comparing diet quality scores with psoriasis severity scores. Look for trends showing whether weeks with better diet quality correspond with weeks of fewer symptoms. Share this data with your dermatologist to inform personalized treatment decisions
This article describes early-stage research conducted in laboratory mice. These findings have not been tested in humans and should not be considered medical advice. Soraphen A is not approved for human use and is not available as a treatment. People with psoriasis should continue following treatment recommendations from their dermatologist. Do not make changes to your psoriasis treatment based on this research. Consult with your healthcare provider before making any dietary or treatment changes. This research is preliminary and results may not apply to humans.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.